TRAF3 and diabetes mellitus: Animal and clinical evidence indicates that the function and expression of TRAF3 are involved in the pathogenesis of a variety of inflammation-related diseases, such as inflammatory bowel disease, liver inflammation, diabetes, bone inflammation, encephalitis, and autoimmune inflammation.